Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Morgera, S.
Right arrow Articles by Neumayer, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgera, S.
Right arrow Articles by Neumayer, H.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1361-1369
© 2003 European Renal Association-European Dialysis and Transplant Association

TNF-{alpha} elimination with high cut-off haemofilters: a feasible clinical modality for septic patients?

Stanislao Morgera1,, Daniela Klonower1, Jens Rocktäschel1, Michael Haase1, Friedrich Priem2, Sabine Ziemer2, Brigitte Wegner3, Hermann Göhl4 and Hans-H. Neumayer1

1 Department of Nephrology, CharitéHumboldt University of Berlin, 2 Laboratory Medicine and Pathobiochemistry, CharitéHumboldt University of Berlin, 3 Institute for Medical Biometrics, CharitéHumboldt University of Berlin and 4 Gambro Corporate Research, Hechingen, Germany

Background. Renal replacement therapies with high cut-off haemofilters are new approaches in the adjuvant therapy of sepsis. We analysed the cytokine elimination capacity of a newly developed polyflux high cut-off haemofilter. Different renal replacement therapies are compared and tested for their clinical feasibility.

Methods. Blood from healthy volunteers (n=15) was incubated for 4 h with 1 mg of endotoxin and then circulated through a closed extracorporeal circuit. A newly developed polyflux haemofilter (P2SX) was used. Haemofiltration, haemodialysis and albumin dialysis were tested. IL-1ra (17 kDa), interleukin-6 (IL-6) (28 kDa), tumour necrosis factor alpha (TNF-{alpha}) (51 kDa), albumin (64 kDa), creatinkinase (CK) (80 kDa) and IgG (140 kDa) were measured in blood and filtrates prior to the initiation and after 5 min, 1, 2 and 4 h.

Results. Haemofiltration was superior to haemodialysis in the clearance capacity of all substances when applied in the 1 l/h ultrafiltration mode. Increasing the ultrafiltration rate/dialysate flow from 1 to 3 l/h led to a significant increase in cytokine clearances (P<0.001). At 3 l/h the differences between haemofiltration and haemodialysis vanished and both techniques achieved comparable cytokine clearances. Median clearance values ranged between 25 and 54 ml/min for interleukin-1 receptor antagonist (IL-1ra), 23 and 42 ml/min for IL-6 and 15 and 28 ml/min for TNF-{alpha}. Albumin loss was highest in the haemofiltration group with albumin clearances ranging between 7 and 13 ml/min. Using diffusion instead of convection significantly reduced the loss of albumin (P<0.01 for 1 l/h, P<0.05 for 3 l/h). Albumin dialysis was able to completely inhibit albumin loss but cytokine clearance capacity was limited.

Conclusions. High cut-off haemofilters achieve high clearances for inflammatory IL-6 and TNF-{alpha}. Due to the high protein loss in haemofiltration, dialysis in combination with balanced protein substitution seems to be a suitable approach for clinical trials.

Keywords: albumin dialysis; haemodialysis; haemofiltration; high cut-off haemofilter; TNF-{alpha} elimination

Correspondence and offprint requests to: Dr Stanislao Morgera, Universitätsklinikum Charité der Humboldt Universität zu Berlin, Medizinische Klinik mit Schwerpunkt Nephrologie am CCM, Schumannstrasse 20–21, D-10098 Berlin, Germany. Email: stanislao.morgera{at}charite.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
T. Rimmele, A. Assadi, M. Cattenoz, O. Desebbe, C. Lambert, E. Boselli, J. Goudable, J. Etienne, D. Chassard, G. Bricca, et al.
High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 421 - 427.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. A. Oeckler and R. D. Hubmayr
Ventilator-associated lung injury: a search for better therapeutic targets
Eur. Respir. J., December 1, 2007; 30(6): 1216 - 1226.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Gardner, D. B. Corry, D. E. Lewis, K. Puellmann, A. W. Beham, W. E. Kaminski, F. Garcia-Bournissen, M. Boragina, S. Ito, M. Takita, et al.
Cytokine Storm and an Anti-CD28 Monoclonal Antibody
N. Engl. J. Med., December 14, 2006; 355(24): 2591 - 2594.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Mariano, V. Fonsato, G. Lanfranco, R. Pohlmeier, C. Ronco, G. Triolo, G. Camussi, C. Tetta, and J. Passlick-Deetjen
Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1116 - 1126.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.